Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Pronk

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
British Journal of Cancer|November 15, 2007
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumoursG Attard, J Kitzen, S P Blagden, et al.
Anti-Cancer Drugs|June 23, 1999
Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancerL van Zuylen, J H Schellens, S H Goey, et al.
British Journal of Cancer|February 12, 1998
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumoursL C Pronk, D Schrijvers, J H Schellens, et al.
Neurology|October 22, 1998
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology GroupM J van den Bent, J M Kros, J J Heimans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumorsL C Pronk, J H Schellens, A S Planting, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
British Journal of Cancer|November 15, 2007
A phase Ib study of pertuzumab, a recombinant humanised antibody to HER2, and docetaxel in patients with advanced solid tumoursG Attard, J Kitzen, S P Blagden, et al.
Anti-Cancer Drugs|June 23, 1999
Phase I and pharmacologic study of the arotinoid Ro 40-8757 in combination with cisplatin and etoposide in patients with non-small cell lung cancerL van Zuylen, J H Schellens, S H Goey, et al.
British Journal of Cancer|February 12, 1998
Phase I study on docetaxel and ifosfamide in patients with advanced solid tumoursL C Pronk, D Schrijvers, J H Schellens, et al.
Neurology|October 22, 1998
Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology GroupM J van den Bent, J M Kros, J J Heimans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1997
Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumorsL C Pronk, J H Schellens, A S Planting, et al.
Pageof 2